Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA”
164 pharma patents match "BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 164 pharmaceutical patents matching "BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10022325
Compositions and methods for the treatment of cancer
granted -
US 9974866
Protein-poly(2-oxazoline) conjugates for enhanced cellular delivery and transport across biological barriers
granted -
US 9962352
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 9895411
Analogs of C5a and methods of using same
granted -
US 9850313
Cancer biomarkers and methods of use thereof
granted -
US 9833427
Creatine ester anti-inflammatory compounds and formulations
granted -
US 9808428
Compositions and methods for the delivery of therapeutics
granted -
US 9789205
Compositions and methods for gene therapy
granted -
US 9782464
Methods and compositions for inhibiting diseases of the central nervous system
granted -
US 9693999
Small molecule RNase inhibitors and methods of use
granted -
US 9580472
Anti-microbial peptides and methods of use thereof
granted -
US 9545452
Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
granted -
US 9517230
Small molecule RNase inhibitors and methods of use
granted -
US 9498533
Drug delivery compositions and methods
granted -
US 9486424
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 9457030
Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders
granted -
US 9403911
Compositions and methods for detection and treatment of cancer
granted -
US 9364443
Compositions and methods for drug delivery
granted -
US 9320814
Polyplexes of hydrophobically-modified siRNA for delivery of siRNA
granted -
US 9315534
Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents
granted -
US 9259465
Methods and compositions for inhibiting diseases of the central nervous system
granted -
US 9233121
Compositions and methods for the treatment of cancer
granted -
US 9233095
Small molecule RNase inhibitors and methods of use
granted -
US 9233164
Water soluble fullerene formulations and methods of use thereof
granted